Hoge Stephen

President

Hoge Stephen has filed 16 SEC Form 4 filings (103 transaction rows) across 1 company, with disclosures dating back to 2025. 14 of those filings fall inside the rolling window. Most recent filing: Oct 16, 2026.

On the most recent filing, Hoge Stephen is listed as President at Moderna, Inc. Inside the rolling window, Hoge Stephen reported no open-market purchases and 8 open-market sales totaling $45.4M in MRNA. The largest disclosed transaction in the window is a sale of 39,145 MRNA shares on Oct 15, 2026, worth $8.6M.

Companies traded

Other insiders at MRNA

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$45.4M

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MRNASale$8.4MOct 16SEC ↗
MRNASale$8.6MOct 16SEC ↗
MRNASale$5.8MSep 16SEC ↗
MRNASale$5.9MSep 16SEC ↗
MRNASale$3.6MJul 16SEC ↗
MRNASale$2.7MJun 17SEC ↗
MRNASale$2.6MMay 18SEC ↗
MRNASale$7.8MFeb 25SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Hoge Stephen made?

Hoge Stephen has filed 16 SEC Form 4 filings (103 transaction rows) across 1 company since 2025.

Which companies does Hoge Stephen trade?

Hoge Stephen has filed SEC Form 4 disclosures for 1 company, including MRNA.

When was Hoge Stephen's most recent SEC Form 4 filing?

Hoge Stephen's most recent SEC Form 4 filing on Tracefour is dated Oct 16, 2026.

What is Hoge Stephen's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Hoge Stephen is listed as President.

What is Hoge Stephen's total buy and sell value in the current window?

Inside the rolling retention window, Hoge Stephen bought $0 and sold $45.4M based on SEC Form 4 filings.

What was Hoge Stephen's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 39,145 MRNA shares on 2026-10-15, worth $8.6M, per SEC Form 4 filings.